Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00194129 · ClinicalTrials.gov registry record · Phase 3
Lithium and Divalproex for the Treatment of Comorbid Rapid Cycling Bipolar Disorder and Substance Abuse Disorder
A Phase 3 study, sponsored by University Hospitals Cleveland Medical Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 31
- Enrollment target
NCT00194129 is a Phase 3 study that has completed, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 31 participants.
The verdict
NCT00194129, a Phase 3 study, has completed, sponsored by University Hospitals Cleveland Medical Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 31 participants
- Enrollment target
Study Summary
This study will determine the efficacy and safety of combination therapy with divalproex and lithium for treating mania in people with rapid cycling bipolar disorder and a substance abuse disorder.
Interventions
- DRUG Placebo
- DRUG Lithium
- DRUG Divalproex
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 1997-11 |
| Est. Completion | 2006-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00194129
The ClinicalTrials.gov registry entry for NCT00194129 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University Hospitals Cleveland Medical Center, which has 230 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00194129 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00194129 about?
NCT00194129 is a clinical study titled "Lithium and Divalproex for the Treatment of Comorbid Rapid Cycling Bipolar Disorder and Substance Abuse Disorder". This study will determine the efficacy and safety of combination therapy with divalproex and lithium for treating mania in people with rapid cycling bipolar disorder and a substance abuse disorder.
What is the current status of trial NCT00194129?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 31 participants. The study started on 1997-11. Estimated completion is 2006-09.
What interventions are being tested in trial NCT00194129?
The interventions under investigation include: Placebo (DRUG), Lithium (DRUG), Divalproex (DRUG).
Who is sponsoring clinical trial NCT00194129?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.